TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Panadact Life Science AB
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
123
|
121
|
100 |
| Financial expenses |
9
|
0
|
0 |
| Earnings before taxes |
14
|
46
|
60 |
| EBITDA |
18
|
28
|
-6 |
| Total assets |
118
|
185
|
165 |
| Current assets |
52
|
131
|
118 |
| Current liabilities |
38
|
94
|
62 |
| Equity capital |
38
|
58
|
81 |
| - share capital |
5
|
4
|
5 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
32.2%
|
31.4%
|
49.1% |
| Turnover per employee |
123
|
121
|
100 |
| Profit as a percentage of turnover |
11.4%
|
38.0%
|
60.0% |
| Return on assets (ROA) |
19.5%
|
24.9%
|
36.4% |
| Current ratio |
136.8%
|
139.4%
|
190.3% |
| Return on equity (ROE) |
36.8%
|
79.3%
|
74.1% |
| Change turnover |
2
|
29
|
-9 |
| Change turnover % |
2%
|
31%
|
-8% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.